Table 2 Cancer diagnoses of women undergoing fertility preservation
From: Responses to fertility treatment among patients with cancer: a retrospective cohort study
| Pre-therapy diagnosis | n (%) |
|---|---|
| Breast | 79 (53.7) |
| Breast cancer typea | |
| Estrogen Receptor Positive | 64 (81.0) |
| Estrogen Receptor Negative | 15 (19.0) |
| Inflammatory | 2 (2.5) |
| HER-2 Positive | 18 (22.8) |
| BRCA statusb | |
| Negative | 51 (64.6) |
| BRCA-1 Positive | 7 (8.9) |
| BRCA-2 Positive | 6 (7.6) |
| BRCA-1 and − 2 Positive | 0 (0.0) |
| Gynecologic | 8 (5.4) |
| Ovarian | 1 (0.7) |
| Endometrial | 4 (2.7) |
| Cervical | 5 (3.4) |
| Hematologic | 38 (25.9) |
| Leukemia | 11 (7.5) |
| Hodgkin’s lymphoma | 18 (12.2) |
| Non-Hodgkin’s lymphoma | 1 (0.7) |
| Myelodysplasia | 2 (1.4) |
| Gastrointestinal | 6 (4.1) |
| Brain | 6 (4.1) |
| Other | 11 (7.5) |
| Total | 147c (100) |